Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Leonardis

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Plos One|October 14, 2015
Epidemiology of CKD Regression in Patients under Nephrology CareSilvio Borrelli, Daniela Leonardis, Roberto Minutolo, et al.
Journal of Hypertension|March 15, 2016
A polymorphism in a major antioxidant gene (Kelch-like ECH-associated protein 1) predicts incident cardiovascular events in chronic kidney disease patients: an exploratory studyAlessandra Testa, Daniela Leonardis, Belinda Spoto, et al.
Kidney International|November 20, 2009
Circulating soluble receptor of advanced glycation end product inversely correlates with atherosclerosis in patients with chronic kidney diseaseGiuseppina Basta, Daniela Leonardis, Francesca Mallamaci, et al.
Kidney International|February 19, 2015
High estimated pulmonary artery systolic pressure predicts adverse cardiovascular outcomes in stage 2-4 chronic kidney diseaseDavide Bolignano, Simone Lennartz, Daniela Leonardis, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 11, 2014
A genetic marker of uric acid level, carotid atherosclerosis, and arterial stiffness: a family-based studyFrancesca Mallamaci, Alessandra Testa, Daniela Leonardis, et al.
Journal of Hypertension|May 9, 2014
A polymorphism in the major gene regulating serum uric acid associates with clinic SBP and the white-coat effect in a family-based studyFrancesca Mallamaci, Alessandra Testa, Daniela Leonardis, et al.
Journal of Clinical Medicine|April 19, 2019
Serum Erythroferrone Levels Associate with Mortality and Cardiovascular Events in Hemodialysis and in CKD Patients: A Two Cohorts StudyBelinda Spoto, Rahul Kakkar, Larry Lo, et al.
Nephron. Clinical Practice|October 24, 2009
Soluble e-selectin is an inverse and independent predictor of left ventricular wall thickness in end-stage renal disease patientsBenedetta Stancanelli, Lorenzo S Malatino, Alessandro Cataliotti, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 26, 2018
Neuropeptide Y and chronic kidney disease progression: a cohort studyCarmine Zoccali, Graziella D'Arrigo, Daniela Leonardis, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 11, 2014
Association of IL-6 and a functional polymorphism in the IL-6 gene with cardiovascular events in patients with CKDBelinda Spoto, Francesco Mattace-Raso, Eric Sijbrands, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Plos One|October 14, 2015
Epidemiology of CKD Regression in Patients under Nephrology CareSilvio Borrelli, Daniela Leonardis, Roberto Minutolo, et al.
Journal of Hypertension|March 15, 2016
A polymorphism in a major antioxidant gene (Kelch-like ECH-associated protein 1) predicts incident cardiovascular events in chronic kidney disease patients: an exploratory studyAlessandra Testa, Daniela Leonardis, Belinda Spoto, et al.
Kidney International|November 20, 2009
Circulating soluble receptor of advanced glycation end product inversely correlates with atherosclerosis in patients with chronic kidney diseaseGiuseppina Basta, Daniela Leonardis, Francesca Mallamaci, et al.
Kidney International|February 19, 2015
High estimated pulmonary artery systolic pressure predicts adverse cardiovascular outcomes in stage 2-4 chronic kidney diseaseDavide Bolignano, Simone Lennartz, Daniela Leonardis, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 11, 2014
A genetic marker of uric acid level, carotid atherosclerosis, and arterial stiffness: a family-based studyFrancesca Mallamaci, Alessandra Testa, Daniela Leonardis, et al.
Journal of Hypertension|May 9, 2014
A polymorphism in the major gene regulating serum uric acid associates with clinic SBP and the white-coat effect in a family-based studyFrancesca Mallamaci, Alessandra Testa, Daniela Leonardis, et al.
Journal of Clinical Medicine|April 19, 2019
Serum Erythroferrone Levels Associate with Mortality and Cardiovascular Events in Hemodialysis and in CKD Patients: A Two Cohorts StudyBelinda Spoto, Rahul Kakkar, Larry Lo, et al.
Nephron. Clinical Practice|October 24, 2009
Soluble e-selectin is an inverse and independent predictor of left ventricular wall thickness in end-stage renal disease patientsBenedetta Stancanelli, Lorenzo S Malatino, Alessandro Cataliotti, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 26, 2018
Neuropeptide Y and chronic kidney disease progression: a cohort studyCarmine Zoccali, Graziella D'Arrigo, Daniela Leonardis, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 11, 2014
Association of IL-6 and a functional polymorphism in the IL-6 gene with cardiovascular events in patients with CKDBelinda Spoto, Francesco Mattace-Raso, Eric Sijbrands, et al.
Pageof 4